Bushu Pharmaceuticals
Celebrating 25 years as Japan's premier CDMO, Bushu Pharmaceuticals is a dedicated contract manufactuer of pharmaceutical products and clinical trial materials.
See below for the Latest Bushu Pharmaceuticals News, Analysis, Profit Results, Share Price Information, and Commentary.
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
Bushu Pharmaceuticals brings home two wins at Healthcare Asia Pharma Awards 2024
It has initiated CO2 emission reduction and wastewater management initiatives to support the environment and the industry.
Most Read
1. OUE Healthcare subsidiary secures majority stake in Rehab Matters 2. Sunway Medical Centre Ipoh to open in Q2 2025 3. Global senior living market to grow by $127.4b by 2028 4. Vietnam’s Tam Anh General Hospital Group unveils new facility in District 8 5. HK Hospital Authority appoints Governance and Structure Reform CommitteeResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
